Jianguo Zhang

Prof. Jianguo Zhang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2018 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MYMengchao Yu
Mengchao Yu
ZLZhijian Liu
Zhijian Liu
YLYuan Liu
Yuan Liu
XZXinyan Zhou
Xinyan Zhou
FSFeng Sun
Feng Sun
XCXi Chen
Xi Chen
The protein tyrosine phosphatase PTP1B, which is encoded by PTPN1, is a ubiquitously expressed nonreceptor protein tyrosine phosphatase. PTP1B has long been known to negatively regulate insulin and leptin receptor signalling. Recently, it was reported to be aberrantly expressed in cancer cells and to function as an important oncogene. In this study, we found that PTP1B protein levels are dramatically increased in breast cancer (BC) tissues and that PTP1B promotes the proliferation, and suppresses the apoptosis, of both HER2‐positive and triple‐negative BC cell lines. Bioinformatics analysis identified that the miRNA, miR‐193a‐3p, might potentially target PTP1B. We demonstrate that miR‐193a‐3p regulates PTP1B in BC cells and that it regulates the proliferation and apoptosis of BC cells by targeting PTP1B, both in vitro and in vivo. In conclusion, this study confirms that PTP1B acts as an oncogene in BC and demonstrates that miR‐193a‐3p can serve as a tumour suppressor gene in BC by targeting PTP1B.

1 June 2017 in Human Pathology
Verified
Journal Article
Closed access
BLBaoquan Liu
Baoquan Liu
FSFei Su
Fei Su
MCMingwei Chen
Mingwei Chen
YLYue Li
Yue Li
XQXiuying Qi
Xiuying Qi
JZJianguo Zhang
Jianguo Zhang

4 April 2020 in Aging
Verified
Journal Article
Open access
YZYiyun Zhang
Yiyun Zhang
JSJiangyun Sun
Jiangyun Sun
YQYuan Qi
Yuan Qi
YWYimin Wang
Yimin Wang
YDYu Ding
Yu Ding
BGBaoliang Guo
Baoliang Guo
LncRNAs have been proven closely correlated to tumor progression. A recent study identified LncRNA TPT1-AS1 (TPT1-AS1) as one of the liver-metastasis associated LncRNAs in colorectal cancer (CRC). In this study, we report that TPT1-AS1 is upregulated in CRC tissues, which is associated with poor prognosis. Functional assays unravel a pro-angiogenesis and metastasis role of TPT1-AS1. Mechanistically, Flexmap 3D assays reveal that TPT1-AS1 upregulates the VEGFA secretion in CRC cells. RNA immunoprecipitation and mRNA stability assays further show that TPT1-AS1 interacts with nuclear factor 90 (NF90) and subsequently promotes the association between NF90 and VEGFA mRNA, which leads to the upregulation of VEGFA mRNA stability. Therefore, we elucidate a new regulatory mechanism of TPT1-AS1 in CRC angiogenesis and targeting the TPT1-AS1/NF90/VEGFA axis may provide a useful strategy for diagnosis and treatment for colorectal cancer patients.

1 April 2021 in Chinese Medical Journal
Verified
Journal Article
Open access
JYJing-Ming Ye
Jing-Ming Ye
BGBao-Liang Guo
Bao-Liang Guo
QLQian Liu
Qian Liu
FMFei Ma
Fei Ma
HLHong-Jin Liu
Hong-Jin Liu
CSChinese Society Of Breast Surgery
Chinese Society Of Breast Surgery
An abstract is unavailable. This article is available as a PDF only.

4 September 2019 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
BLBaoquan Liu
Baoquan Liu
FSFei Su
Fei Su
XLXiaohong Lv
Xiaohong Lv
WZWenbo Zhang
Wenbo Zhang
XSXiaochen Shang
Xiaochen Shang
JZJianguo Zhang
Jianguo Zhang

19 March 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
YLYufei Lv
Yufei Lv
DLDongxu Lv
Dongxu Lv
XLXiaohong Lv
Xiaohong Lv
PXPing Xing
Ping Xing
JZJianguo Zhang
Jianguo Zhang
YZYafang Zhang
Yafang Zhang
Breast cancer represents the number one cause of cancer-associated mortality globally. The most aggressive molecular subtype is triple negative breast cancer (TNBC), of which limited therapeutic options are available. It is well known that breast cancer prognosis and tumor sensitivity toward immunotherapy are dictated by the tumor microenvironment. Breast cancer gene expression profiles were extracted from the METABRIC dataset and two TNBC clusters displaying unique immune features were identified. Activated immune cells formed a large proportion of cells in the high infiltration cluster, which correlated to a good prognosis. Differentially expressed genes (DEGs) extracted between two heterogeneous subtypes were used to further explore the underlying immune mechanism and to identify prognostic biomarkers. Functional enrichment analysis revealed that the DEGs were predominately related to some processes involved in activation and regulation of innate immune signaling. Using network analysis, we identified two modules in which genes were selected for further prognostic investigation. Validation by independent datasets revealed that CXCL9 and CXCL13 were good prognostic biomarkers for TNBC. We also performed comparisons between the above two genes and immune markers (CYT, APM, TILs, and TIS), as well as cell checkpoint marker expressions, and found a statistically significant correlation between them in both METABRIC and TCGA datasets. The potential of CXCL9 and CXCL13 to predict chemotherapy sensitivity was also evaluated. We found that the CXCL9 and CXCL13 were good predictors for chemotherapy and their expressions were higher in chemotherapy-responsive patients in contrast to those who were not responsive. In brief, immune infiltrate characterization on TNBC revealed heterogeneous subtypes with unique immune features allowed for the identification of informative and reliable characteristics representative of the local immune tumor microenvironment and were potential candidates to guide the management of TNBC patients.